Japan’s Ministry of Health, Labor and Welfare (MHLW) on March 5 unveiled the revised NHI prices for drugs subject to…
HOME > ARCHIVE
ARCHIVE
- Korosho Issues Vision for Medical Devices Industry
October 6, 2008
- Will Distribution Practices Be Improved? Part 4
October 6, 2008
- NHO to Jointly Purchase Reagents through Bids in All Blocks
October 6, 2008
- BUSINESS NEWS IN BRIEF
October 6, 2008
- Increased Use of Generics Makes Management of Drugs Brought by Patients More Difficult
October 6, 2008
- SEMINAR／Expiration of Patents to Weigh Heavily on Japanese Pharmas
October 6, 2008
- Most Patients Consult Doctors, Not Pharmacists, Regarding Selection of Generics
October 6, 2008
- FDA Continues to Review NDA for Prasugrel
October 6, 2008
- Preparedness for New PAL Differs Greatly among OTC Drug Makers
October 6, 2008
- Argatroban to Be Temporarily Excluded from DPC Payment
October 6, 2008
- Levemir Reduces Risk of Nocturnal Hypoglycemia: Novo Nordisk
October 6, 2008
- Tamiflu Ban in Teenagers Should Not Be Lifted: Medwatcher Japan
October 6, 2008
- H. Pylori Eradication Should Be Covered by Health Insurance
October 6, 2008
- NanoCarrier Ties Up with Taiwan Company for Nanoplatin
September 29, 2008
- Pfizer to Start Clinical Trial for Fibromyalgia
September 29, 2008
- Bristol-Myers Applies for Abatacept
September 29, 2008
- R&D NEWS IN BRIEF
September 29, 2008
- NEW PRODUCTS／Kyowa Medex Launches New Reagent to Determine HDL-C
September 29, 2008
- NEW PRODUCT／Julina Launched as Japan's First Oral Estradiol Product
September 29, 2008
- Will Distribution Practices Be Improved? Part 3
September 29, 2008
ページ
Japan is ramping up its push to spread regional formularies nationwide, a policy expected to standardize treatments, strengthen supply resilience,…
We had just gotten off a call with a client in Europe, and we’d received a bit of an earful. “Philip,” the client pressed, “what can this candidate bring to us? We know what he does, but what has he…
Japan’s Central Social Insurance Medical Council (Chuikyo) on November 5 approved the reimbursement listing for a slate of new medicines,…
The Japanese government on March 7 announced new NHI prices to be applied in the FY2025 drug price revision, revealing…
The Japanese government approved a bill to amend the Pharmaceuticals and Medical Devices (PMD) Act at its Cabinet meeting on…
Japan’s health ministry doled out regulatory approvals for a throng of new medicines on December 27 including Eli Lilly’s obesity…
Japan’s all-important reimbursement policy panel on December 20 approved an outline of drug pricing reforms for FY2024, which enshrines a…